Aviatrix(R) Launches Zero Trust for Workloads: Pervasive Cross-Cloud Enforcement for AI and Cloud Native Environments

Aviatrix(R) Launches Zero Trust for Workloads: Pervasive Cross-Cloud Enforcement for AI and Cloud Native Environments New Product Line Delivers Inline Zero Trust Enforcement and Continuous Visibility Across VMs, Containers, Kubernetes, and Serverless Workloads GlobeNewswire November 12, 2025 Santa Clara, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Aviatrix(R) today introduced Zero Trust for Workloads, a new […]

NeOnc Technologies Reports Updated Clinical Results

NeOnc Technologies Reports Updated Clinical Results Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 GlobeNewswire November 12, 2025 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage

GrowGeneration to Exhibit Commercial Cultivation Solutions at 2025 CEAg World Conference and Expo

GrowGeneration to Exhibit Commercial Cultivation Solutions at 2025 CEAg World Conference and Expo GlobeNewswire November 12, 2025 DENVER, Nov. 12, 2025 (GLOBE NEWSWIRE) — GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration” or the “Company”), one of the nation's largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced it

ReconAfrica Provides Drilling Update at Kavango West 1X Well

ReconAfrica Provides Drilling Update at Kavango West 1X Well GlobeNewswire November 12, 2025 Depth extended beyond original TD due to indications of hydrocarbons while drillingExtensive wireline logging planned CALGARY, Alberta, Nov. 12, 2025 (GLOBE NEWSWIRE) — Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) is pleased to

Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide

Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide GlobeNewswire November 12, 2025 Woodland, CA, Nov. 12, 2025 (GLOBE NEWSWIRE) — Genvor, Inc. (OTCQB: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, announced today the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,458,684, titled “Transgenic

SailPoint Announces Date of Fiscal Third Quarter 2026 Results Conference Call and Participation in Upcoming Investor Conference

SailPoint Announces Date of Fiscal Third Quarter 2026 Results Conference Call and Participation in Upcoming Investor Conference GlobeNewswire November 12, 2025 AUSTIN, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) — SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, will report its fiscal third quarter 2026 financial results before the US markets open on Tuesday,

GlobalTech Corporation Reports Third Quarter 2025 Financial Results

GlobalTech Corporation Reports Third Quarter 2025 Financial Results GlobeNewswire November 12, 2025 RENO, Nev., Nov. 12, 2025 (GLOBE NEWSWIRE) — GlobalTech Corporation (OTCID:GTLK)(“GlobalTech” or the “Company”), a technology holding company specializing in artificial intelligence (AI) and big data solutions, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter Financial

TON Strategy Company Reports Third Quarter 2025 Financial Results and Provides Update on TON Treasury Strategy

TON Strategy Company Reports Third Quarter 2025 Financial Results and Provides Update on TON Treasury Strategy GlobeNewswire November 12, 2025 LAS VEGAS, Nov. 12, 2025 (GLOBE NEWSWIRE) — TON Strategy Company (“TON Strategy” or the “Company”) (Nasdaq: TONX), a digital asset treasury company dedicated to holding Toncoin ($TON), today reported financial results for the third

New Study Finds LifeVantage’s P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health

New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health New in vitro research shows P84 influences key gut peptides – including one by more than 1,000% – supporting cellular pathways tied to regulation, repair, and restoration GlobeNewswire November 12, 2025 SALT LAKE CITY, Nov. 12, 2025 (GLOBE

Theriva(TM) Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results

Theriva(TM) Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results GlobeNewswire November 12, 2025 – Expanded data for VCN-01 (zabilugene almadenorepvec) in metastatic pancreatic ductal adenocarcinoma (PDAC) from the VIRAGE Phase 2b trial presented at the European Society for Medical Oncology (ESMO) Annual Congress 2025 – – Next generation oncolytic virus VCN-12 preclinical data

Scroll to Top